Matinas BioPharma
mat expanded access compassionate use program | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
14 of 31
Similar slides by Matinas BioPharma
See diffirences between slides (animation)
Investor Presentation
March 2024
mat expanded access compassionate use program demonstrated efficacy in treatment of patients with limited treatment options | Matinas BioPharma
Investor Presentation
February 2024
mat expanded access compassionate use program demonstrated efficacy in treatment of patients with limited treatment options | Matinas BioPharma
Investor Presentation
January 2024
mat expanded access compassionate use program demonstrated efficacy in treatment of patients with limited treatment options | Matinas BioPharma
Related slides by other companies
Palantir
Results
February 2021
expanded vantage program and enabled army to free up billion for reinvestment army vantage became a chartered product office within army data and analytics platforms portfolio in its mission is to enable the army to see itself by empowering army users at all echelons to make real time data driven decisions els tis mission | Palantir
Main Street Capital
Fixed Income
August 2023
at the market equity program equity program provides efficient and low cost access to equity capital provides access to equity capital to match growth of investments on an as needed basis provides significant economic cost savings compared to traditional overnight equity offerings provides permanent capital to match indefinite or long term holding period for investments facilitates maintenance of conservative leverage position issued equity is accretive to per share provides significant benefits traditional overnight equity offerings raised net proceeds of million since inception in | Main Street Capital
Main Street Capital
Fixed Income
May 2023
at the market equity program equity program provides efficient and low cost access to equity capital provides access to equity capital to match growth of investments on an as needed basis provides significant economic cost savings compared to traditional overnight equity offerings provides permanent capital to match indefinite or long term holding period for investments facilitates maintenance of conservative leverage position issued equity is accretive to per share provides significant benefits traditional overnight equity offerings raised net proceeds of million since inception in | Main Street Capital
Sigilon Therapeutics
Investor Presentation
October 2022
expanded program will enable blood penetration brain | Sigilon Therapeutics
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io